Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert et al. · Journal of the American College of Cardiology · 2019 · 1.9K citations · Full text

Medicine, Cardiology, Preventive Medicine +16

Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography

Helmut Baumgartner, Judy Hung, Javier Bermejo et al. · Journal of the American Society of Echocardiography · 2017 · 1.3K citations · Full text

Medicine, Cardiology, Radiology +17

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

Sotirios Tsimikas, Ewa Karwatowska‐Prokopczuk, Ioanna Gouni‐Berthold et al. · New England Journal of Medicine · 2020 · 1K citations · Full text

Life Sciences, Genetics, Pharmacotherapy +17

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults

Glen J. Pearson, George Thanassoulis, Todd J. Anderson et al. · Canadian Journal of Cardiology · 2021 · 833 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14